Affiliation: St. Gallen
- Insulin-like growth factors and cancerGregor Fürstenberger
Center for Tumour Detection and Prevention, St Gallen, Switzerland
Lancet Oncol 3:298-302. 2002..IGFBPs, especially IGFBP3, have independent effects on cell growth, for example, IGFBP3 has proapoptotic activities both dependent on and independent of p53...
- Insulin-like growth factors and breast cancerG Furstenberger
Zentrum für Tumordiagnostik und Prävention, St Gallen, Switzerland
Onkologie 26:290-4. 2003..Based on interactions with other receptors, including estrogen and epidermal growth factor receptors, combined targeted therapies may improve breast cancer treatment...
- Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancerGregor Fürstenberger
Center for Tumor Detection and Prevention, Rorschacherstrasse 150, CH 9006 St Gallen, Switzerland
Breast 15:64-8. 2006..IGF-1 levels significantly correlated with IGFBP-3 levels before and during chemotherapy. In conclusion, these chemotherapy regimens do not seem to modulate IGF-1 or IGFBP-3 levels in a favourable or unfavourable way...
- Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesisG Furstenberger
Center for Tumor Detection and Prevention, St Gallen, Switzerland
Br J Cancer 93:793-8. 2005..Thus, CD146 real-time PCR may be an easy and reliable approach to quantify CEC in peripheral blood samples and could facilitate the integration of CEC measurements in clinical studies exploring the efficacy of antiangiogenic therapies...
- Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancerG Furstenberger
Center for Tumor Detection and Prevention, Rorschacherstrasse 150, 9006 St Gallen, Switzerland
Br J Cancer 94:524-31. 2006..Since this mobilisation of EPC may contribute to tumour neovascularisation an early antiangiogenic therapy in combination with chemotherapy could be beneficial for the success of cancer therapy...
- Complete remission of a metastatic neuroendocrine tumor of the pancreas with capecitabine (Xeloda) monotherapyGregor Fürstenberger
Tumor Center ZeTuP St Gallen and Chur, Rorschacherstrasse 150, CH 9006 St Gallen, Switzerland
Cancer Chemother Pharmacol 61:347-8. 2008